"Group ","Number of axons_{2} per 0.05 mm (n of optic nerves) ","± SD ","p vs control ","p vs iOHT injured eye ","Brn3a-positive cells per mm retina ± SD (n of eyes) ","p vs control ","p vs iOHT injured eye ","Iba1-positive cells per mm retina ± SD (n of eyes) ","p vs control ","p vs iOHT injured eye ","IgG depositions per mm retina ± SD (n of eyes) ","p vs control ","p vs iOHT injured eye "
Control eyes,"22,267 ± 1408 (12)",,0.0003,95.2 ± 12.6 (13),,0.0001,5.2 ± 1.1 (14),,0.01,0.5 ± 0.4 (14),,0.002
iOHT fellow eye,"21,943 ± 1510 (12)",0.98,0.001,82.0 ± 9.9 (11),0.07,0.02,6.7 ± 1.3 (10),0.03,1,1.1 ± 0.4 (10),0.045,0.75
iOHT injured eye,"19,624 ± 1709 (12)",0.0003,,66.0 ± 13.2 (11),0.0001,,6.7 ± 1.3 (12),0.01,,1.3 ± 0.6 (10),0.002,
iOHT + Belimumab,"21,838 ± 802 (9)",0.96,0.008,80.9 ± 10.0 (9),0.08,0.06,6.6 ± 1.0 (9),0.08,0.99,0.9 ± 0.2 (9),0.3,0.3
fellow eye,,,,,,,,,,,,
iOHT+ Belimumab,"20,593 ± 609 (9)",0.07,0.5,74.2 ± 9.5 (8),0.005,0.6,6.5 ± 1.0 (8),0.1,0.99,0.9 ± 0.4 (8),0.3,0.4
injured eye,,,,,,,,,,,,
